The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
HCIL · Healthcare · Shallow moat
Doesn't clear the bar
The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
NDRA · Healthcare · Shallow moat
Doesn't clear the bar
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
| Measure | HCIL | AORT | ADMT | NDRA |
|---|---|---|---|---|
| Moat Score (0–100) | 40 (highest) | 40 (highest) | 40 (highest) | 40 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 63 | 75 (highest) | 59 | — |
| Pricing power | 53 | 100 (highest) | 65 | 61 |
| Returns on capital | 0 | 0 | 4 (highest) | 0 |
| Balance-sheet safety | — | 18 | 28 | 55 (highest) |
| Capital allocation | 44 (highest) | 7 | 44 (highest) | 44 (highest) |
| No price data | No price data | No price data | No price data | |
| Market cap | Not reported | $1.2B | $2.6M | $7M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2026 | FY2025 |